MARKET

TELA

TELA

TELA BIO, INC.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

14.03
+0.28
+2.04%
Closed 16:41 06/01 EDT
OPEN
13.43
PREV CLOSE
13.75
HIGH
14.20
LOW
13.43
VOLUME
55.85K
TURNOVER
--
52 WEEK HIGH
18.88
52 WEEK LOW
5.25
MARKET CAP
160.05M
P/E (TTM)
-5.3829
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average TELA stock price target is 16.50 with a high estimate of 20.00 and a low estimate of 14.00.

EPS

TELA News

More
TELA Bio to Present at the Jefferies Virtual Healthcare Conference
GlobeNewswire · 3d ago
JMP Securities Maintains Market Outperform on TELA Bio, Lowers Price Target to $20
JMP Securities maintains TELA Bio (NASDAQ:TELA) with a Market Outperform and lowers the price target from $22 to $20.
Benzinga · 05/13 14:26
TELA Bio, Inc. (TELA) CEO Antony Koblish on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/13 04:50
TELA Bio EPS misses by $0.06, beats on revenue
TELA Bio (NASDAQ:TELA): Q1 GAAP EPS of -$0.63 misses by $0.06. Revenue of $3.73M (+12.7% Y/Y) beats by $0.06M. Press Release
seekingalpha · 05/13 01:07
TELA Bio Q1 EPS $(0.63) vs $(27.00) In Same Qtr. Last Year, Sales $3.726M Beat $3.670M Estimate
TELA Bio (NASDAQ:TELA) reported quarterly sales of $3.726 million which beat the analyst consensus estimate of $3.670 million by 1.53 percent. This is a 12.70 percent increase over sales of $3.306 million the same
Benzinga · 05/12 20:12
TELA Bio Announces First Quarter 2020 Financial Results
MALVERN, Pa., May 12, 2020 -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new.
GlobeNewswire · 05/12 20:05
U.S. IPO Week Ahead: GAN Bets On Itself In A One-IPO Week
Seeking Alpha - Article · 05/02 20:11
TELA Bio to Announce First Quarter 2020 Financial Results and Host Conference Call on May 12, 2020
MALVERN, Pa., April 28, 2020 -- TELA Bio, Inc. ("TELA Bio") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new.
GlobeNewswire · 04/28 11:00

Industry

Medical Equipment, Supplies & Distribution
-0.27%
Healthcare Equipment & Supplies
+0.10%

Hot Stocks

Symbol
Price
%Change

About TELA

TELA Bio Inc. is a medical technology company. The Company is focused on designing, developing and marketing tissue reinforcement materials for soft tissue reconstruction. It offers a portfolio of products and solutions for care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. Its portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), can be used for ventral hernia repair and abdominal wall reconstruction, inguinal hernia repair and hiatal hernia repair. Its OviTex PRS Reinforced Tissue Matrix (OviTex PRS) addresses needs in plastic and reconstructive surgery. OviTex PRS product is designed for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft tissue repair or reinforcement in plastic and reconstructive surgery.
More

Webull offers kinds of TELA Bio Inc stock information, including NASDAQ:TELA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TELA stock news, and many more online research tools to help you make informed decisions.